Building the Future of Israeli Biotech

About

Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israeli-based biotech companies.

Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages. We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance. The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

Strategy

“We invest in Israeli and Israeli related clinical stage biotechnology and pharmaceutical companies with exceptional technologies or product opportunities based on strong scientific rationale and commercial potential.”

Team

General Partners

David Sidransky, MD linkedin

Co-Founder and General Partner

Yuval Cabilly, Ph.D. linkedin

Co-Founder and General Partner

Ido Zairi linkedin

Co-Founder and General Partner

Staff
Sarit Steinberg, Adv. linkedin

General Counsel at Israel Biotech Fund

Matti Davis, Ph.D. linkedin

Analyst at Israel Biotech Fund

Venture Advisors
Sol Barer, Ph.D.

Former Chairman and CEO, Celgene

Jeff Kindler linkedin

Former Chairman and CEO, Pfizer

Harlan Weisman, MD linkedin

Former J&J Company Group Chairman, Pharmaceutical R&D; CSO & CTO, Medical Devices

Robert Spiegel, MD linkedin

Former Chief Medical Officer, Schering-Plough

Steven Nichtberger, MD linkedin

Former Head of Marketing, Merck

Eddy Shalev linkedin

Founder & Managing Partner, Genesis Partners

Murray A. Goldberg

Former CFO, Regeneron Pharmaceuticals, Inc.


Edward C. Saltzmanlinkedin

President & Founder, Defined Health

Michael G. Bator linkedin

CFO, Trek Therapeutics; Partner, Certus Advisory

Ron Bentsur, MBA

CEO, UroGen Pharma; Former CEO, Keryx Biopharmaceuticals

linkedin Stanley Bernard, MD, MBA

President, Bernard Associates

Joshua B. Barer linkedin

Managing Director, Sunflower Life Sciences

Andrew J. Einhorn linkedin

CFO, Edge Therapeutics; Financial Executive & Entrepreneur

Larry Ellberger

Chairman, Celldex Therapeutics

Jonathan Fassberg linkedin

Founder & CEO, the Trout Group

linkedinRobert Glassman, MD

Vice Chairman & MD, Global Healthcare Investment Banking, Credit Suisse

Michael Ingber, MD linkedin

Director, the Center for Specialized Women’s Health

John Oppenheimer, MD

Director of Clinical Research at Pulmonary, Allergy Associates & Clinical Professor of Medicine at the New Jersey Medical School

Daniel Pascheles, Ph.D.linkedin

CEO & Partner, Molekule Consulting LLC

Aran Ron, MD linkedin

President, Health Strategies Consultants

Benjamin Maisano linkedin

CTO, CareDox

image1
Yaron Werber, MD, MBAlinkedin

Chief Business & Financial Officer, Ovid Therapeutics Inc.

Partners

Additional short description about our partners

Portfolio

Israel Biotech Fund Portfolio Companies

News

Gamida Cell $40MM Financing to support its Phase 3 Trial

June 19th, 2017|Comments Off on Gamida Cell $40MM Financing to support its Phase 3 Trial

Israel Biotech Fund participated in Gamida Cell’s $40MM financing round which shall support the ongoing Phase 3 trial of the its FDA Breakthrough Designated clinical-stage product, NiCord, to […]

Israel Biotech Fund Co-Founder and General Partner Recognized for Contribution to Liquid Biopsy Innovation

April 3rd, 2017|Comments Off on Israel Biotech Fund Co-Founder and General Partner Recognized for Contribution to Liquid Biopsy Innovation

Israel Biotech Fund is proud to announce that its Co-Founder and General Partner...

Israel Biotech Fund invests in Pharma Two B

February 27th, 2017|Comments Off on Israel Biotech Fund invests in Pharma Two B

A $30MM funding round in Pharma Two B was led by Israel Biotech Fund, which  syndicated the investment with leading US and Israeli investors. Read the full […]

Israel Biotech Fund begins investing

July 3rd, 2016|Comments Off on Israel Biotech Fund begins investing

Israel Biotech Fund, founded to make investments in the Israeli biotech industry, today selected cancer drug developer Vidac for its first investment.
Read the full Article

MORE NEWS

Contact info

Israel Biotech Fund
Ruhrberg Science Center, Bell Entrance, 4th Floor
3 Pekeris Street, Rabin Science Park
Rehovot 7670212
Israel

972-72-2514-175

We would be happy to hear from you and learn more about your company and technology.
Please feel free to contact us at 
Info@IsraelBiotechFund.com